Atrial Fibrillation Trial, Recruiting NCT06007872 Sponsor: The Cleveland Clinic Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06007872
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who meet the standard medical guidelines for receiving a commercially available Watchman device (a small implant used to reduce stroke risk in people with a certain type of irregular heartbeat)
  • People who are not currently enrolled in another active clinical trial

Who may not be able to join:

  • People who cannot have a type of heart imaging procedure called a TEE (a camera passed down the throat to look at the heart) during the procedure, and who would need a different imaging method called ICE instead
  • People who are having an additional heart procedure called an ablation at the same time as the Watchman implant
  • People who have previously had an incomplete surgical or catheter-based procedure to close off a part of the heart called the left atrial appendage
  • People whose heart anatomy is expected to make it difficult to pass the necessary equipment through the wall between the upper chambers of the heart — for example, because they have an existing closure device for a hole in the heart (such as a PFO or ASD repair device) already in place

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Oussama Wazni, MD, The Cleveland Clinic

Phone: 216-444-2131

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 December 2022
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Successful Watchman implantation using intracardiac echocardiography (ICE) guidance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov